Naveed Shams
Vorsitzender bei InnFocus, Inc.
Profil
Derzeit hat Naveed K. Shams die Position des Chief Scientific Officer, General Manager-R&D bei Santen Pharmaceutical Co., Ltd., Chairman bei InnFocus, Inc. (eine Tochtergesellschaft von Santen Pharmaceutical Co., Ltd.) und Chief Scientific Officer bei ProQR Therapeutics NV. In seiner früheren Laufbahn war er CMO, Senior Vice President-Research & Development bei OPKO Health, Inc, Senior Scientist & Glaucoma Group Leader-Discovery bei Storz Ophthalmics, Inc, President, Chief Executive Officer & Director bei Santen, Inc, Senior Medical Director bei Genentech, Inc, Director-Clinical Science bei Novartis Ophthalmics, Inc und Member-Research Faculty beim Schepens Eye Research Institute. Naveed K. Shams erhielt einen Abschluss am Dow Medical College und einen Doktortitel an der University of South Carolina.
Aktive Positionen von Naveed Shams
| Unternehmen | Position | Beginn |
|---|---|---|
InnFocus, Inc.
 InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Vorsitzender | - |
Ehemalige bekannte Positionen von Naveed Shams
| Unternehmen | Position | Ende |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
| OPKO HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.06.2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2007 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2003 |
| Storz Ophthalmics, Inc. | Corporate Officer/Principal | 01.03.1998 |
Ausbildung von Naveed Shams
| University of South Carolina | Doctorate Degree |
| Dow Medical College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| PROQR THERAPEUTICS N.V. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Schepens Eye Research Institute, Inc.
 The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Commercial Services |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
| Storz Ophthalmics, Inc. | |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
